|
MechanismTGF-β inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with RADBIO USA, INC.
0 Patents (Medical) associated with RADBIO USA, INC.
100 Deals associated with RADBIO USA, INC.
100 Translational Medicine associated with RADBIO USA, INC.